Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Helix Opco LLC
Headquarters: San Francisco, CA, United States of America
Website: http://www.helix.com
Year Founded: 2015
Status: Private
BioCentury | Jun 4, 2021
Finance
June 3 Quick Takes: venBio’s new $550M fund, plus Innovent-AnHeart, Ajax, Scynexis and more
Just 15 months after closing its $394 million third fund, venBio has completed its $550 million Global Strategic Fund IV, a vehicle designed to invest in 12-15 start-ups and in some cases provide
BioCentury | May 12, 2021
Management Tracks
Salter-Cid becomes CSO of Flagship’s new Pioneering Medicines unit; plus Veracyte, Catalent, Zoetis, Gracell, Galecto and more
Flagship Pioneering announced Luisa Salter-Cid as CSO of its new Pioneering Medicines division. Salter-Cid, a 13-year veteran of Bristol Myers Squibb Co. (NYSE:BMY), was most recently CSO at
BioCentury | Feb 27, 2021
Product Development
How variant surveillance could drive a sequencing boom
Infrastructure to monitor SARS-CoV-2 mutations could pay dividends for AMR, cancer and the next pandemic
BioCentury | Jan 21, 2021
Product Development
The evolving zeitgeist of COVID-19 testing
What paradigms could stick, and what questions remain, for COVID-19 testing one year in
BioCentury | Oct 8, 2020
Finance
Data Bytes: RADx funding recipients
NIH and BARDA granted six additional awards to COVID-19 diagnostics developers this week, bringing its total investment in the RADx Initiative for scale-up and manufacturing of new COVID-19 testing
BioCentury | Aug 24, 2015
Finance
App store with a twist
Why Warburg, Illumina think time is ripe for a genomics app store
Items per page:
1 - 8 of 8